Non-peptidic natural products that target and modulate oxytocin and arginine vasopressin receptors: Opportunities and challenges.

The ability to target the oxytocin and vasopressin receptors is of high therapeutic value due to their clinical relevance in wide range of neuropsychiatric conditions spanning from anxiety to schizophrenia. Despite the massive therapeutic potential in modulating this system, the only clinically approved small molecule-based therapeutics (Mozavaptan, Conivaptan and Tolvaptan) are for use in the periphery. Cyclotide mimetics of the native neuropeptides are well explored in the literature although these scaffolds are unsuitable for application to the central nervous system. This work highlights non-peptidic natural products that are active within the neurohypophysial system that may be used to inspire future drug discovery endeavours.

• Publication year

  2025

• Venue

  Journal of Pharmacological Sciences

• Publication date

  2025-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jphs.2025.04.004PMID 40436486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxytocin and vasopressin signaling in health and disease.

  2024cited by this paper
• Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products

  2024cited by this paper
• The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial

  2024cited by this paper
• Oxytocin attenuates microglial activation and restores social and non-social memory in APP/PS1 Alzheimer model mice

  2023cited by this paper
• Pilot Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Feasibility of an Intranasal Oxytocin in Improving Social Cognition in Individuals Living with Alzheimer’s Disease

  2023cited by this paper
• Vasopressin receptor antagonists: a patent summary (2018-2022)

  2023cited by this paper
• The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review

  2023cited by this paper
• Myristicin: From its biological effects in traditional medicine in plants to preclinical studies and use as ecological remedy in plant protection

  2023cited by this paper
• Natural product drug discovery and drug design: two approaches shaping new pharmaceutical development.

  2023cited by this paper
• The physiology and pharmacology of oxytocin in labor and in the peripartum period.

  2023cited by this paper
• Comparative LC-MS/MS-based molecular networking, DNA fingerprinting, and in vitro anti-Helicobacter pylori activity of three Egyptian Ficus cultivars.

  2023cited by this paper
• Synthesis and Evaluation of Rutin–Hydroxypropyl β-Cyclodextrin Inclusion Complexes Embedded in Xanthan Gum-Based (HPMC-g-AMPS) Hydrogels for Oral Controlled Drug Delivery

  2023cited by this paper
• Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders

  2023cited by this paper
• Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era

  2023cited by this paper
• Effect of St. John’s Wort (Hypericum perforatum L.) on Male Sexual and Reproductive Health: A Narrative Review

  2023cited by this paper
• [6]-Shogaol and [6]-Gingerol active ingredients may improve neuropathic pain by suppressing cytokine levels in an experimental model

  2023cited by this paper
• Cassiae Semen: A comprehensive review of botany, traditional use, phytochemistry, pharmacology, toxicity, and quality control.

  2023cited by this paper
• Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer's Disease.

  2022cited by this paper
• The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease

  2022cited by this paper
• Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels

  2022cited by this paper
• Comprehensive investigation on the metabolism of emodin both in vivo and in vitro.

  2022cited by this paper
• A Review of the Traditional Uses, Phytochemistry and Pharmacology of Bryophyllum pinnatum (Lam.) (Crassulaceae)

  2022cited by this paper
• Tannins medical / pharmacological and related applications: A critical review

  2021cited by this paper
• Evaluation of Blood-Brain Barrier Permeability of Polyphenols, Anthocyanins, and Their Metabolites.

  2021cited by this paper
• Pharmacokinetics of Anthraquinones from Medicinal Plants

  2021cited by this paper
• Flavonoids: structure–function and mechanisms of action and opportunities for drug development

  2021cited by this paper
• The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study

  2021cited by this paper
• In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist

  2021cited by this paper
• Natural products in drug discovery: advances and opportunities

  2021cited by this paper
• Bryophyllum pinnatum Compounds Inhibit Oxytocin-Induced Signaling Pathways in Human Myometrial Cells

  2021cited by this paper
• Vasopressin V1B Receptor Antagonists as Potential Antidepressants

  2021cited by this paper
• Pharmacological and Therapeutic Potential of Myristicin: A Literature Review

  2021cited by this paper
• Kamikihito rescued depressive-like behaviors and hippocampus neurogenesis in chronic restraint stress rats

  2021cited by this paper
• Identification of oxytocin receptor activating chemical components from traditional Japanese medicines

  2021cited by this paper
• Neuroprotective Effect of Aurantio-Obtusin, a Putative Vasopressin V1A Receptor Antagonist, on Transient Forebrain Ischemia Mice Model

  2021cited by this paper
• Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study.

  2020cited by this paper
• Establishing GPCR Targets of hMAO Active Anthraquinones from Cassia obtusifolia Linn Seeds Using In Silico and In Vitro Methods

  2020cited by this paper
• Recent advancements in synthetic methodologies of 3-substituted phthalides and their application in the total synthesis of biologically active natural products

  2020cited by this paper
• Emodin Derivatives as Multi-Target-Directed Ligands Inhibiting Monoamine Oxidase and Antagonizing Vasopressin V1A Receptors

  2020cited by this paper
• Luteolin, a potent human monoamine oxidase-A inhibitor and dopamine D4 and vasopressin V1A receptor antagonist.

  2020cited by this paper
• Blood-brain barrier permeability study of ginger constituents.

  2020cited by this paper
• Personalizing the Treatment of Substance Use Disorders.

  2020cited by this paper
• Yohimbine as a Starting Point to Access Diverse Natural Product-Like Agents with Re-programmed Activities against Cancer-Relevant GPCR Targets.

  2020cited by this paper
• Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment.

  2020cited by this paper
• Global Burden of Disease and the Impact of Mental and Addictive Disorders

  2019cited by this paper
• Targeting the Oxytocin System: New Pharmacotherapeutic Approaches.

  2019cited by this paper
• Vasopressin enhances human preemptive strike in both males and females

  2019cited by this paper
• Clinical applications of the naturally occurring or synthetic glycosylated low molecular weight drugs.

  2019cited by this paper
• The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial

  2019cited by this paper
• Neuroprotective Effects of 6-Shogaol and Its Metabolite, 6-Paradol, in a Mouse Model of Multiple Sclerosis

  2018cited by this paper
• The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation

  2018cited by this paper
• Oxytocin receptor antagonist atosiban impairs consolidation, but not reconsolidation of contextual fear memory in rats.

  2018cited by this paper
• Two new naphthalenic lactone glycosides from Cassia obtusifolia L. seeds

  2018cited by this paper
• Absorption and Metabolism of Luteolin in Rats and Humans in Relation to in Vitro Anti-inflammatory Effects.

  2018cited by this paper
• The gastrointestinal behavior of saponins and its significance for their bioavailability and bioactivities

  2018cited by this paper
• Ursolic acid in health and disease

  2018cited by this paper
• Neuroprotective effects of Cassia tora against paraquat-induced neurodegeneration: relevance for Parkinson’s disease

  2018cited by this paper
• Effects of Oxytocin on Fear Memory and Neuroinflammation in a Rodent Model of Posttraumatic Stress Disorder

  2018cited by this paper
• On-line incubation and real-time detection by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry for rapidly analyzing metabolites of anthraquinones in rat liver microsomes.

  2018cited by this paper
• Flavonoid metabolism: the interaction of metabolites and gut microbiota

  2018cited by this paper
• Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery.

  2017cited by this paper
• A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.

  2017cited by this paper
• Potential of Bryophyllum pinnatum as a Detrusor Relaxant: An in Vitro Exploratory Study

  2017cited by this paper
• Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species

  2017cited by this paper
• Early Intranasal Vasopressin Administration Impairs Partner Preference in Adult Male Prairie Voles (Microtus ochrogaster)

  2017cited by this paper
• Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability

  2017cited by this paper
• A Tryptoline Ring-Distortion Strategy Leads to Complex and Diverse Biologically Active Molecules from the Indole Alkaloid Yohimbine.

  2017cited by this paper
• Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.

  2017cited by this paper
• Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases

  2017cited by this paper
• Oxytocin stimulates hippocampal neurogenesis via oxytocin receptor expressed in CA3 pyramidal neurons

  2017cited by this paper
• Treatment of anxiety disorders

  2017cited by this paper
• Haematopoietic effects of Angelica sinensis root cap polysaccharides against lisinopril-induced anaemia in albino rats

  2016cited by this paper
• Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system

  2016cited by this paper
• Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date

  2016cited by this paper
• The Pharmacological Potential of Rutin

  2016cited by this paper
• Promising Inhibitory Effects of Anthraquinones, Naphthopyrone, and Naphthalene Glycosides, from Cassia obtusifolia on α-Glucosidase and Human Protein Tyrosine Phosphatases 1B

  2016cited by this paper
• Anthraquinones As Pharmacological Tools and Drugs

  2016cited by this paper
• Chemical Composition and Antimicrobial Activity of Essential Oils of Ficus asperifolia Miq. and Ficus capensis Thunb from Nigeria

  2016cited by this paper
• Metabolism of kurarinone by human liver microsomes and its effect on cytotoxicity

  2016cited by this paper
• Bryophyllum pinnatum and Related Species Used in Anthroposophic Medicine: Constituents, Pharmacological Activities, and Clinical Efficacy

  2016cited by this paper
• Cassia obtusifolia seed ameliorates amyloid β-induced synaptic dysfunction through anti-inflammatory and Akt/GSK-3β pathways.

  2016cited by this paper
• Herbal Medicine for Anxiety, Depression and Insomnia

  2015cited by this paper
• Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies

  2015cited by this paper
• Effects of d- and l-limonene on the pregnant rat myometrium in vitro

  2015cited by this paper
• Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach.

  2015cited by this paper
• Gingerols and shogaols: Important nutraceutical principles from ginger.

  2015cited by this paper
• Proteochemometric modelling coupled to in silico target prediction: an integrated approach for the simultaneous prediction of polypharmacology and binding affinity/potency of small molecules

  2015cited by this paper
• Isolation of Luteolin and Luteolin-7-O-glucoside from Dendranthema morifolium Ramat Tzvel and Their Pharmacokinetics in Rats.

  2015cited by this paper
• Inhibition of porcine detrusor contractility by the flavonoid fraction of Bryophyllum pinnatum--a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome.

  2015cited by this paper
• Sophora flavescens Ait.: Traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine.

  2015cited by this paper
• Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial

  2015cited by this paper
• Time-Dependent Metabolism of Luteolin by Human UDP-Glucuronosyltransferases and Its Intestinal First-Pass Glucuronidation in Mice.

  2015cited by this paper
• Evolution of oxytocin pathways in the brain of vertebrates

  2014cited by this paper
• The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.

  2014cited by this paper
• A standardized extract of the fruit of Ziziphus jujuba (Jujube) induces neuronal differentiation of cultured PC12 cells: a signaling mediated by protein kinase A.

  2014cited by this paper
• Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

  2014cited by this paper
• Role of the vasopressin 1b receptor in rodent aggressive behavior and synaptic plasticity in hippocampal area CA2

  2014cited by this paper
• Co-Occurrence of Substance use Disorders with other Psychiatric Disorders: Implications for Treatment Services

  2014cited by this paper
• Enantiospecific Synthesis and Biological Investigations of a Nuphar Alkaloid: Proposed Structure of a Castoreum Component.

  2014cited by this paper
• Phytol, a Diterpene Alcohol from Chlorophyll, as a Drug against Neglected Tropical Disease Schistosomiasis Mansoni

  2014cited by this paper

• Unravelling the effects of specific ingredients of kamishoyosan in reducing aggressive biting behavior in chronically isolated mice to inanimate objects.

  2025cites this paper
• Oxytocin, Vasopressin and Stress: A Hormetic Perspective

  2025cites this paper
• 68Ga-Labeled Peptides Targeting Oxytocin Receptor in Breast Cancer Using Linchpin Chemistry for Tandem Peptide Cyclization and Radiometal Chelator Incorporation.

  2025cites this paper